Oral Proteins and Peptides are the formulations that are orally administered by the patient. Usually, formulations containing proteins and peptides are administered via intravenous and subcutaneous route due to instability and sensitivity towards body fluids.
Portland, OR -- (SBWIRE) -- 12/28/2017 -- Oral route of administration is very convenient route; however, the bioavailability of proteins and peptides is less, when administered orally due to degradation of amino acids in gastrointestinal tract. With the advancement in technology formulation containing protein and peptides are introduced in the market that can be orally administered with no change in therapeutic activity and pharmacokinetic aspects.
The market for oral protein and peptides is expected to grow due to technological advancements, R&D activities and increase in prevalence of chronic disorders. High cost of R&D activities is the major challenge for oral proteins and peptides market.
Get the PDF of Oral Proteins and Peptides insights @ https://www.alliedmarketresearch.com/request-toc-and-sample/378
Oral Proteins and Peptides Market analysis by Drugs
The market is segmented into Linaclotide, Ostora, IN-105(Insulin), Plecantide and others. Insulin is used mostly amongst the various oral proteins and peptides that are being developed.
Oral Proteins and Peptides Market analysis by Technology
The market is segmented into Gastrointestinal Permeation Enhancement Technology (GIPET), Eligen, Peptelligence, Oral antibody platform, Multi-Matrix Systems (MMX) and others. GIPET, Eligen and Peptelligence are some of the prominent technologies used in oral protein and peptides formulations development.
Oral Proteins and Peptides Market analysis by Geography
Geographically, the market is segmented into North America, Europe, Asia-Pacific and the LAMEA. North America is the most eminent market of oral proteins and peptides market.
Competitive Landscape
Zydus cadilla Healthcare, Pfizer, Inc., Roche, Inc., Sanofi-Aventis LLC, Abbott Laboratories, Novartis AG are the major key players of this market. Many large and small companies are doing in-house research for developing new technologies. Several proteins and peptides are in preclinical and discovery stage.
Do purchase inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/378
KEY BENEFITS
- Understanding of drivers and restraints helps to develop business strategies according to the business environment
- Market entry and market expansion strategies can be planned on the basis of segmentation of market
- Analysis of strategies adopted by key players helps to strengthen market position
- Long term profit and growth strategies can be tailored through porter's five forces model and SWOT analysis